US FDA accepts biologics license application from Lupin for pegfilgrastim biosimilar
This BLA expands the company's oncology portfolio
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Cyrus Karkaria
‘Lupin has gained significant momentum towards development of biosimilar products with primary…
Lupin Biotech, with a new-age R&D facility in Pune, is developing and commercialising biosimilars globally. The successful…